JPY 191.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 3.97 Billion JPY | -24.6% |
2022 | 5.27 Billion JPY | -29.0% |
2021 | 7.43 Billion JPY | -20.05% |
2020 | 9.29 Billion JPY | 83.51% |
2019 | 5.06 Billion JPY | 15.65% |
2018 | 4.38 Billion JPY | 20.33% |
2017 | 3.64 Billion JPY | -5.35% |
2016 | 3.84 Billion JPY | -13.71% |
2015 | 4.45 Billion JPY | -13.32% |
2014 | 5.14 Billion JPY | 31.15% |
2013 | 3.92 Billion JPY | -2.67% |
2012 | 4.02 Billion JPY | 14.46% |
2011 | 3.52 Billion JPY | 12.01% |
2010 | 3.14 Billion JPY | -44.26% |
2009 | 5.63 Billion JPY | 48.27% |
2008 | 3.8 Billion JPY | 11.91% |
2007 | 3.39 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 FY | 3.97 Billion JPY | -24.6% |
2023 Q3 | 929.1 Million JPY | -1.15% |
2023 Q2 | 939.95 Million JPY | -12.33% |
2023 Q1 | 1.07 Billion JPY | 0.17% |
2023 Q4 | 1.03 Billion JPY | 11.8% |
2022 Q1 | 1.52 Billion JPY | -22.62% |
2022 FY | 5.27 Billion JPY | -29.0% |
2022 Q4 | 1.07 Billion JPY | -1.26% |
2022 Q3 | 1.08 Billion JPY | -32.14% |
2022 Q2 | 1.59 Billion JPY | 4.66% |
2021 FY | 7.43 Billion JPY | -20.05% |
2021 Q1 | 1.87 Billion JPY | -23.13% |
2021 Q3 | 1.87 Billion JPY | 8.76% |
2021 Q2 | 1.71 Billion JPY | -8.13% |
2021 Q4 | 1.97 Billion JPY | 5.47% |
2020 Q1 | 2.07 Billion JPY | 23.07% |
2020 FY | 9.29 Billion JPY | 83.51% |
2020 Q2 | 2.44 Billion JPY | 17.79% |
2020 Q3 | 2.33 Billion JPY | -4.42% |
2020 Q4 | 2.43 Billion JPY | 4.1% |
2019 Q1 | 925.29 Million JPY | -28.61% |
2019 Q2 | 1.1 Billion JPY | 19.54% |
2019 Q3 | 1.34 Billion JPY | 21.85% |
2019 Q4 | 1.68 Billion JPY | 25.25% |
2019 FY | 5.06 Billion JPY | 15.65% |
2018 FY | 4.38 Billion JPY | 20.33% |
2018 Q3 | 1.04 Billion JPY | -4.79% |
2018 Q2 | 1.09 Billion JPY | 15.58% |
2018 Q1 | 947.47 Million JPY | -10.53% |
2018 Q4 | 1.29 Billion JPY | 24.31% |
2017 Q1 | 806.68 Million JPY | -20.41% |
2017 Q4 | 1.05 Billion JPY | 23.01% |
2017 Q3 | 860.93 Million JPY | -5.86% |
2017 Q2 | 914.51 Million JPY | 13.37% |
2017 FY | 3.64 Billion JPY | -5.35% |
2016 Q1 | 781.96 Million JPY | -27.52% |
2016 FY | 3.84 Billion JPY | -13.71% |
2016 Q3 | 894.75 Million JPY | -22.65% |
2016 Q4 | 1.01 Billion JPY | 13.28% |
2016 Q2 | 1.15 Billion JPY | 47.92% |
2015 Q2 | 1.29 Billion JPY | 22.69% |
2015 FY | 4.45 Billion JPY | -13.32% |
2015 Q4 | 1.07 Billion JPY | 4.59% |
2015 Q3 | 1.03 Billion JPY | -20.27% |
2015 Q1 | 1.05 Billion JPY | -12.5% |
2014 Q2 | 1.35 Billion JPY | 22.74% |
2014 Q3 | 1.47 Billion JPY | 9.12% |
2014 Q4 | 1.2 Billion JPY | -18.52% |
2014 FY | 5.14 Billion JPY | 31.15% |
2014 Q1 | 1.1 Billion JPY | 3.05% |
2013 Q2 | 995.95 Million JPY | 9.26% |
2013 Q4 | 1.07 Billion JPY | 13.66% |
2013 FY | 3.92 Billion JPY | -2.67% |
2013 Q3 | 942.71 Million JPY | -5.35% |
2013 Q1 | 911.57 Million JPY | -22.72% |
2012 Q2 | 1.1 Billion JPY | 31.92% |
2012 Q3 | 902.46 Million JPY | -18.53% |
2012 Q4 | 1.17 Billion JPY | 30.7% |
2012 FY | 4.02 Billion JPY | 14.46% |
2012 Q1 | 839.68 Million JPY | -17.19% |
2011 FY | 3.52 Billion JPY | 12.01% |
2011 Q2 | 900.77 Million JPY | 9.56% |
2011 Q3 | 783.3 Million JPY | -13.04% |
2011 Q4 | 1.01 Billion JPY | 29.45% |
2011 Q1 | 822.17 Million JPY | 4.62% |
2010 Q2 | 608.63 Million JPY | -33.91% |
2010 Q1 | 920.9 Million JPY | -2.11% |
2010 FY | 3.14 Billion JPY | -44.26% |
2010 Q3 | 827.33 Million JPY | 35.93% |
2010 Q4 | 785.88 Million JPY | -5.01% |
2009 Q2 | 1.56 Billion JPY | 34.76% |
2009 FY | 5.63 Billion JPY | 48.27% |
2009 Q4 | 940.76 Million JPY | -52.3% |
2009 Q3 | 1.97 Billion JPY | 26.08% |
2009 Q1 | 1.16 Billion JPY | 21.67% |
2008 Q1 | 1.03 Billion JPY | 0.0% |
2008 FY | 3.8 Billion JPY | 11.91% |
2008 Q4 | 953.99 Million JPY | -1.91% |
2008 Q3 | 972.58 Million JPY | 14.99% |
2008 Q2 | 845.78 Million JPY | -17.89% |
2007 FY | 3.39 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 26.45 Billion JPY | 84.953% |
DNA Chip Research Inc. | 490.46 Million JPY | -711.47% |
Cosmo Bio Company,Limited | 9.34 Billion JPY | 57.388% |
H.U. Group Holdings, Inc. | 236.95 Billion JPY | 98.32% |
FALCO HOLDINGS Co., Ltd. | 43 Billion JPY | 90.746% |
BML, Inc. | 137.96 Billion JPY | 97.115% |
Human Metabolome Technologies, Inc. | 1.34 Billion JPY | -195.76% |